1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.
| Published in: | Lancet Vol. 408; no. 10553; pp. 440 - 453 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
Lancet
Aug2026
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195787511&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 195787511 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: Aug2026 vid: 408 iid: 10553 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 195787511 10.1016/S0140-6736(26)00665-3 195787511 ppf: 440 ppct: 13 formats: tig: atl: 1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial. aug: au: Sotomi, Yohei Kozuma, Ken Higuchi, Yoshiharu Nakazawa, Gaku Morino, Yoshihiro Ando, Kenji Ako, Junya Tanabe, Kengo Muramatsu, Takashi Kobayashi, Ken Ichibori, Yasuhiro Ishihara, Takayuki Hirooka, Keiji Suwa, Satoru Warisawa, Takayuki Naganuma, Toru Kikuchi, Atsushi Shutta, Ryu Okamoto, Naotaka Tanabe, Yasuhiro affil: Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Osaka, Osaka, Japan sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|